We use own cookies and thirds to offer you better service More information Accept
Back to News

May. 2018

Qualigen launches Tadalafil 5 mg for ED and BPH


Tadalafilo Qualigen® 5 mg is a medication for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH)

May 23, 2018 - Laboratorios Qualigen launched Tadalafilo Qualigen® 5 mg, a drug to treat males with erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). This medication is the only one in Spain for men presenting both pathologies in a single daily intake, in a 5 mg dose.


Both ED and BPH are common disorders in males and can occurr simultaneously in a same patient.


Tadalafilo Qualigen® 5 mg requires a prescription for dispensing and is presented in the form of film-coated tablets.